QUOTE AND NEWS
TheStreet.com  Jul 24  Comment 
NEW YORK (TheStreet) -- Centene is in the health care sweetspot thanks to being part of one of the leading industry groups this year, health care providers. Centene shares, at $80, are up 35% for the year to date. Concerns about the launch of...
Benzinga  Jul 23  Comment 
In a report published Wednesday, Bank of America analyst Kevin Fischbeck reiterated a Buy rating on Centene (NYSE: CNC), and raised the price target from $89.00 to $94.00. In the report, Bank of America noted, “CNC reported Q2 EPS of $0.79,...
Market Intelligence Center  Jul 22  Comment 
Centene (CNC) was selected by MarketIntelligenceCenter.com’s trade-picking algorithms today after trading between $75.34 and $77.07 on Monday before closing at $75.58. A diagonal spread using a long position in the Jan. '15 $45.00 call and a...
Motley Fool  Jul 21  Comment 
Centene (CNC) is enjoying significant enrollment growth thanks to Medicaid expansion. Here's what you need to know heading into Centene's second-quarter earnings.
Benzinga  Jul 21  Comment 
Below are the top mid-cap health care plans stocks on the NYSE and the NASDAQ in terms of profit margin. The trailing-twelve-month profit margin at Centene (NYSE: CNC) is 2.60%. Centene's EPS for the same period is $3.02. The...
Motley Fool  Jul 20  Comment 
Medicaid enrollment has climbed by 80,000 in Texas despite the state opting out of Medicaid expansion.
Benzinga  Jun 27  Comment 
In a report published Friday, Sterne Agee analyst Brian Wright initiated coverage on Centene (NYSE: CNC) with a Buy rating and $87.00 price target. In the report, Sterne Agee noted, “Centene has become the premier Medicaid pure-play and...
TheStreet.com  Jun 16  Comment 
NEW YORK (TheStreet) -- UBS increased its price target on Centene  to $70 and set a "neutral" rating based on substantial growth opportunities. The stock closed at $74.13 on Friday. Must Read: Warren Buffett's 25 Favorite Stocks STOCKS TO...
Benzinga  Jun 16  Comment 
In a report published Monday, Morgan Stanley analyst Andrew Schenker reiterated an Equal-Weight rating on Centene (NYSE: CNC). In the report, Morgan Stanley noted, “CNC signaled that it would update its current EPS guidance during its 2Q...
Benzinga  Jun 13  Comment 
Below are the top mid-cap health care plans stocks on the NYSE and the NASDAQ in terms of return on equity. The trailing-twelve-month return on equity at Centene (NYSE: CNC) is 25.10%. Centene's revenue for the same period is $11.80...





You may also be interested in articles related to Centene (CNC):
 




References

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki